Nearly 30 percent of clinical trial participants withdraw before study completion in certain therapeutic areas, according … Why Pharma Companies Struggle With Trial Participant RetentionRead more
Drug development
The Biggest Reasons Clinical Trials Fail to Scale
Clinical trials are the cornerstone of pharmaceutical innovation, providing the evidence necessary to bring safe and … The Biggest Reasons Clinical Trials Fail to ScaleRead more
Why Phase II Clinical Trials Are the Graveyard of Drug Development
Nearly 60 percent of drug candidates that enter Phase II clinical trials never advance to Phase … Why Phase II Clinical Trials Are the Graveyard of Drug DevelopmentRead more
How Pharma Marketing Impacts Clinical Trial Success
In the United States, nearly 80 percent of clinical trials fail to meet their original enrollment … How Pharma Marketing Impacts Clinical Trial SuccessRead more
The Real Reasons Promising Drugs Fail Before Phase II
Drug development is one of the most capital-intensive and high-risk sectors in the pharmaceutical industry. While … The Real Reasons Promising Drugs Fail Before Phase IIRead more